MAVS coordination of antiviral innate immunity

Journal of Virology

Volumn 89, Issue 14, 2015, Pages 6974-6977

  Vazquez, Christine ^a   Horner, Stacy M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; MELANOMA DIFFERENTIATION ASSOCIATED PROTEIN 5; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 4A; PROTEIN MAVS; SIGNAL TRANSDUCING ADAPTOR PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANTIVIRAL SUSCEPTIBILITY; ARTICLE; CELLULAR DISTRIBUTION; CYTOKINE RESPONSE; CYTOPLASM; ENDOPLASMIC RETICULUM MEMBRANE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE LOCATION; HEPATITIS C VIRUS; IMMUNOREGULATION; INNATE IMMUNITY; INTRACELLULAR SIGNALING; MITOCHONDRION; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RNA VIRUS INFECTION; VIRUS IMMUNITY; BIOLOGICAL MODEL; ENDOPLASMIC RETICULUM; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; RNA VIRUS; SIGNAL TRANSDUCTION;

RNA VIRUSES;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ENDOPLASMIC RETICULUM; HOST-PATHOGEN INTERACTIONS; IMMUNITY, INNATE; MITOCHONDRIA; MODELS, BIOLOGICAL; RNA VIRUSES; SIGNAL TRANSDUCTION;

EID: 84931091785     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01918-14     Document Type: Article

References (23)

1. Kumar H, Kawai T, Kato H, Sato S, Takahashi K, Coban C, Yamamoto M, Uematsu S, Ishii KJ, Takeuchi O, Akira S. 2006. Essential role of IPS-1 in innate immune responses against RNA viruses. J Exp Med 203: 1795-1803. http://dx.doi.org/10.1084/jem.20060792.
2. Dixit E, Boulant S, Zhang Y, Lee AS, Odendall C, Shum B, Hacohen N, Chen ZJ, Whelan SP, Fransen M, Nibert ML, Superti-Furga G, Kagan JC. 2010. Peroxisomes are signaling platforms for antiviral innate immunity. Cell 141:668-681. http://dx.doi.org/10.1016/j.cell.2010.04.018.
3. Horner SM, Liu HM, Park HS, Briley J, Gale M, Jr. 2011. Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus. Proc Natl Acad Sci USA 108:14590-14595. http://dx.doi.org/10.1073/pnas.1110133108.
4. Seth RB, Sun L, Ea CK, Chen ZJ. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF3. Cell 122:669-682. http://dx.doi.org/10.1016/j.cell.2005.08.012.
5. Edwards AP, Xie Y, Bowers L, DiMaio D. 2013. Compensatory mutants of the bovine papillomavirus E5 protein and the platelet-derived growth factor beta receptor reveal a complex direct transmembrane interaction. J Virol 87:10936-10945. http://dx.doi.org/10.1128/JVI.01475-13.
6. Chan YK, Gack MU. 2015. RIG-I-like receptor regulation in virus infection and immunity. Curr Opin Virol 12C:7-14. http://dx.doi.org/10.1016/j.coviro.2015.01.004.
7. Liu HM, Loo YM, Horner SM, Zornetzer GA, Katze MG, Gale M, Jr. 2012. The mitochondrial targeting chaperone 14-3-3epsilon regulates a RIG-I translocon that mediates membrane association and innate antiviral immunity. Cell Host Microbe 11:528-537. http://dx.doi.org/10.1016/j.chom.2012.04.006.
8. Jiang X, Kinch LN, Brautigam CA, Chen X, Du F, Grishin NV, Chen ZJ. 2012. Ubiquitin-induced oligomerization of the RNA sensors RIG-I and MDA5 activates antiviral innate immune response. Immunity 36:959-973. http://dx.doi.org/10.1016/j.immuni.2012.03.022.
9. Koshiba T. 2013. Mitochondrial-mediated antiviral immunity. Biochim Biophys Acta 1833:225-232. http://dx.doi.org/10.1016/j.bbamcr.2012.03.005.
10. Lad SP, Yang G, Scott DA, Chao TH, Correia JDS, de la Torre JC, Li E. 2008. Identification of MAVS splicing variants that interfere with RIGI/MAVS pathway signaling. Mol Immunol 45:2277-2287. http://dx.doi.org/10.1016/j.molimm.2007.11.018.
11. Brubaker SW, Gauthier AE, Mills EW, Ingolia NT, Kagan JC. 2014. A bicistronic MAVS transcript highlights a class of truncated variants in antiviral immunity. Cell 156:800-811. http://dx.doi.org/10.1016/j.cell.2014.01.021.
12. Castanier C, Zemirli N, Portier A, Garcin D, Bidere N, Vazquez A, Arnoult D. 2012. MAVS ubiquitination by the E3 ligase TRIM25 and degradation by the proteasome is involved in type I interferon production after activation of the antiviral RIG-I-like receptors. BMC Biol 10:44. http://dx.doi.org/10.1186/1741-7007-10-44.
13. Jacobs JL, Coyne CB. 2013. Mechanisms of MAVS regulation at the mitochondrial membrane. J Mol Biol 425:5009-5019. http://dx.doi.org/10.1016/j.jmb.2013.10.007.
14. Liu S, Cai X, Wu J, Cong Q, Chen X, Li T, Du F, Ren J, Wu YT, Grishin NV, Chen ZJ. 2015. Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Science 347:aaa2630. http://dx.doi.org/10.1126/science.aaa2630.
15. Odendall C, Dixit E, Stavru F, Bierne H, Franz KM, Durbin AF, Boulant S, Gehrke L, Cossart P, Kagan JC. 2014. Diverse intracellular pathogens activate type III interferon expression from peroxisomes. Nat Immunol 15:717-726. http://dx.doi.org/10.1038/ni.2915.
16. Anggakusuma, Frentzen A, Gurlevik E, Yuan Q, Steinmann E, Ott M, Staeheli P, Schmid-Burgk J, Schmidt T, Hornung V, Kuehnel F, Pietschmann T. 2015. Control of hepatitis C virus replication in mouse liverderived cells by MAVS-dependent production of type I and type III interferons. J Virol 89:3833-3845. http://dx.doi.org/10.1128/JVI.03129-14.
17. Guan K, Zheng Z, Song T, He X, Xu C, Zhang Y, Ma S, Wang Y, Xu Q, Cao Y, Li J, Yang X, Ge X, Wei C, Zhong H. 2013. MAVS regulates apoptotic cell death by decreasing K48-linked ubiquitination of voltagedependent anion channel 1. Mol Cell Biol 33:3137-3149. http://dx.doi.org/10.1128/MCB.00030-13.
18. Hayashi T, Rizzuto R, Hajnoczky G, Su TP. 2009. MAM: more than just a housekeeper. Trends Cell Biol 19:81-88. http://dx.doi.org/10.1016/j.tcb.2008.12.002.
19. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, Bartenschlager R, Tschopp J. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437:1167-1172. http://dx.doi.org/10.1038/nature04193.
20. Ding Q, Huang B, Lu J, Liu YJ, Zhong J. 2012. Hepatitis C virus NS3/4A protease blocks IL-28 production. Eur J Immunol 42:2374-2382. http://dx.doi.org/10.1002/eji.201242388.
21. Baril M, Racine ME, Penin F, Lamarre D. 2009. MAVS dimer is a crucial signaling component of innate immunity and the target of hepatitis C virus NS3/4A protease. J Virol 83:1299-1311. http://dx.doi.org/10.1128/JVI.01659-08.
22. van Zuylen WJ, Doyon P, Clement JF, Khan KA, D'Ambrosio LM, Do F, St-Amant-Verret M, Wissanji T, Emery G, Gingras AC, Meloche S, Servant MJ. 2012. Proteomic profiling of the TRAF3 interactome network reveals a new role for the ER-to-Golgi transport compartments in innate immunity. PLoS Pathog 8:e1002747. http://dx.doi.org/10.1371/journal.ppat.1002747.
23. Horner SM, Wilkins C, Badil S, Iskarpatyoti J, Gale M, Jr. 2015. Proteomic analysis of mitochondrial-associated ER membranes (MAM) during RNA virus infection reveals dynamic changes in protein and organelle trafficking. PLoS One 10:e0117963. http://dx.doi.org/10.1371/journal.pone.0117963.